Comments
Loading...

Pacira BioSciences

PCRXNASDAQ
Logo brought to you by Benzinga Data
$14.73
0.080.55%
Pre-Market: 5:58 AM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$94.00
Lowest Price Target1
$8.00
Consensus Price Target1
$39.69

Pacira BioSciences (NASDAQ:PCRX) Stock, Analyst Ratings, Price Targets, Forecasts

Pacira BioSciences Inc has a consensus price target of $39.69 based on the ratings of 13 analysts. The high is $94 issued by Wedbush on February 28, 2022. The low is $8 issued by Truist Securities on August 13, 2024. The 3 most-recent analyst ratings were released by Truist Securities, RBC Capital, and HC Wainwright & Co. on August 13, 2024, August 12, 2024, and August 12, 2024, respectively. With an average price target of $20.33 between Truist Securities, RBC Capital, and HC Wainwright & Co., there's an implied 38.04% upside for Pacira BioSciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
May
3
1
Jul
2
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Truist Securities
RBC Capital
HC Wainwright & Co.
Needham
JP Morgan

1calculated from analyst ratings

Analyst Ratings for Pacira BioSciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Pacira BioSciences (PCRX) stock?

A

The latest price target for Pacira BioSciences (NASDAQ:PCRX) was reported by Truist Securities on August 13, 2024. The analyst firm set a price target for $8.00 expecting PCRX to fall to within 12 months (a possible -45.69% downside). 29 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Pacira BioSciences (PCRX)?

A

The latest analyst rating for Pacira BioSciences (NASDAQ:PCRX) was provided by Truist Securities, and Pacira BioSciences downgraded their sell rating.

Q

When was the last upgrade for Pacira BioSciences (PCRX)?

A

The last upgrade for Pacira BioSciences Inc happened on August 3, 2023 when TD Cowen raised their price target to $50. TD Cowen previously had a market perform for Pacira BioSciences Inc.

Q

When was the last downgrade for Pacira BioSciences (PCRX)?

A

The last downgrade for Pacira BioSciences Inc happened on August 13, 2024 when Truist Securities changed their price target from $30 to $8 for Pacira BioSciences Inc.

Q

When is the next analyst rating going to be posted or updated for Pacira BioSciences (PCRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pacira BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pacira BioSciences was filed on August 13, 2024 so you should expect the next rating to be made available sometime around August 13, 2025.

Q

Is the Analyst Rating Pacira BioSciences (PCRX) correct?

A

While ratings are subjective and will change, the latest Pacira BioSciences (PCRX) rating was a downgraded with a price target of $30.00 to $8.00. The current price Pacira BioSciences (PCRX) is trading at is $14.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch